Magna Lab Inc (YBGJ) 10-Q Quarterly Report January 2021

Cover - shares	9 Months Ended
Cover - shares	Nov. 30, 2020	Jan. 19, 2021
Cover [Abstract]
Entity Registrant Name	Yubo International Biotech Ltd
Entity Central Index Key	0000895464
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--02-28
Entity Small Business	true
Entity Shell Company	true
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Nov. 30, 2020
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2021
Entity Common Stock Shares Outstanding		118,177,885
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes

Please wait while we load the requested 10-Q report or click the link below:

https://last10k.com/sec-filings/report/895464/000164033421000131/yubo_10q.htm

View differences made from one quarter to another to evaluate Magna Lab Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ) — *Sample 10-K Year-over-Year (YoY) Comparison*

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were ~~removed~~ , added and changed by Magna Lab Inc.

Continue

Assess how Magna Lab Inc's management team is paid from their Annual Proxy

Magna Lab Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

Voting Procedures
Board Members
Executive Team
Salaries, Bonuses, Perks
Peers / Competitors

Continue

Rating
Learn More

Filter Sentiment:

All

Positive

Negative

Filter Category:

All

Financial

Other

Filter Subcategory:

All

Other

Inside Magna Lab Inc's 10-Q Quarterly Report:

Other - Other Highlight
Notes payable included 12% unsecured notes payable to MALLC, in the aggregate principal amount of approximately $687,000, plus approximately $762,000 of interest accrued.

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Material Contracts, Statements, Certifications & more

Magna Lab Inc provided additional information to their SEC Filing as exhibits

Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification

Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification

Exhibit 32.1: Section 1350 Certification

Exhibit 32.2: Section 1350 Certification

Ticker: YBGJ
CIK: 895464
Form Type: 10-Q Quarterly Report
Accession Number: 0001640334-21-000131
Submitted to the SEC: Tue Jan 19 2021 4:44:05 PM EST
Accepted by the SEC: Tue Jan 19 2021
Period: Monday, November 30, 2020
Industry: Electromedical And Electrotherapeutic Apparatus